Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis

FTT Lai, EWW Chan, L Huang, CL Cheung… - Journal of the American …, 2022 - jacc.org
Background Association between messenger RNA (mRNA) COVID-19 vaccines and
myocarditis has aroused public concern over vaccine safety. Objectives The goal of this …

Myocarditis after Covid-19 vaccination in a large health care organization

G Witberg, N Barda, S Hoss, I Richter… - … England Journal of …, 2021 - Mass Medical Soc
Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …

Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults

A Simone, J Herald, A Chen, R Nayak… - International Journal of …, 2022 - Elsevier
Introduction Myocarditis has been reported following the second dose of COVID-19 mRNA
vaccination. Whether administration of additional doses of COVID-19 vaccines further …

Myocarditis following mRNA Covid-19 vaccination: A pooled analysis

I Bellos, V Karageorgiou, D Viskin - Vaccine, 2022 - Elsevier
Background Post-marketing surveillance studies have raised concerns of increased
myocarditis rates following coronavirus disease-19 (Covid-19) mRNA vaccines. The present …

Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination

Y Perez, ER Levy, AY Joshi, A Virk… - Clinical Infectious …, 2022 - academic.oup.com
Background Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines
(Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the …

Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines

Z Naveed, J Li, J Wilton, M Spencer, M Naus… - Journal of the American …, 2022 - jacc.org
Background Postmarketing evaluations have linked myocarditis to COVID-19 mRNA
vaccines. However, few population-based analyses have directly compared the safety of the …

Incidence, clinical presentation, and management of myocarditis following mRNA-based COVID-19 vaccines: a brief report

S Saeed, L Käsk, R Rajani, TH Larsen - Cardiology, 2022 - karger.com
Background: Recent surveillance studies following nationwide mass vaccination are
investigating rare complications such as myocarditis, pericarditis, and thromboembolic …

Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series

DY Park, S An, A Kaur, S Malhotra, A Vij - Clinical Cardiology, 2022 - Wiley Online Library
Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had …

Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines

DK Shay, TT Shimabukuro, F DeStefano - JAMA cardiology, 2021 - jamanetwork.com
Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …

Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: a pragmatic approach

C Anastassopoulou, S Hatziantoniou… - International Journal of …, 2022 - Elsevier
Background Complications following COVID-19 vaccination, particularly with mRNA
vaccines, rarely include myocarditis and pericarditis. This work principally aimed at defining …